After Hours
$
4.12
Change
-0.04 -0.96%
Volume
Volume 1,188
May 26, 2023, 6:37 p.m.
Quotes are delayed by 20 min
Previous close
$ 4.10
$ 4.16
Change
+0.06 +1.46%
Day low
Day high
$4.03
$4.20

52 week low
52 week high
$0.78
$7.25

Market cap
$225.12M
Average volume
3.13M
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.62
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on IFRX
-
InflaRx stock upgraded to buy from neutral at Guggenheim
- Emily Bary
-
InflaRx upgraded to strong buy from outperform at Raymond James
- Tomi Kilgore
-
InflaRx upgraded to outperform from market perform at Raymond James
- Tomi Kilgore
-
4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens
- Barron's Online
-
InflaRx downgraded to market perform at BMO Capital
- Tomi Kilgore
-
InflaRx downgraded to hold from buy at SunTrust RH
- Tomi Kilgore
-
InflaRx stock price target cut to $5 from $55 at SunTrust RH
- Tomi Kilgore
-
InflaRx downgraded to market perform from outperform at Raymond James
- Tomi Kilgore
-
InflaRx stock price target cut to $4 from $67 at SVB Leerink
- Tomi Kilgore
-
InflaRx downgraded to market perform from outperform at SVB Leerink
- Tomi Kilgore
-
Cronos Group and Campbell Soup Stock Rise as the Dow Pops Again
- Barron's Online
-
InflaRx stock tumbles 82% after reporting disappointing trial results
- Ciara Linnane
-
InflaRx stock price target raised to $67 vs. $65 at JPMorgan
- Ciara Linnane
-
InflaRx price target raised to $44 vs. $42 at Raymond James
- Ciara Linnane
-
InflaRx stock price target raised to $67 from $42 at SVB Leerink
- Tomi Kilgore
-
InflaRx stock price target raised to $65 from $42 at J.P. Morgan
- Tomi Kilgore
-
Samsung Warns on Revenue, but Trade Hopes Lift Global Stocks
- Barron's Online
-
InflaRx started at buy with $55 stock price target at SunTrust RH
- Tomi Kilgore
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For December 4, 2017
- Benzinga.com
Other News on IFRX
Press Releases on IFRX
-
InflaRx Reports Full Year 2022 Financial and Operating Results
- GlobeNewswire
-
InflaRx Reports Third Quarter 2022 Financial & Operating Results
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com